Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2002 Aug;78(4):267–270. doi: 10.1136/sti.78.4.267

15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery

L Mandelbrot 1, P Msellati 1, N Meda 1, V Leroy 1, R Likikouet 1, P Van de Perre 1, L Dequae-Merchadoux 1, F Sylla-Koko 1, A Ouangre 1, T Ouassa 1, R Ramon 1, L Gautier-Charpenti 1, M Cartoux 1, M Dosso 1, F Dabis 1, C Welffens-Ekra 1
PMCID: PMC1744488  PMID: 12181464

Abstract

Objectives: To study mother to child HIV-1 transmission (MTCT) and infant mortality following benzalkonium chloride (BC) disinfection.

Methods: A randomised, double blind phase II placebo controlled trial. Women testing positive for HIV-1 infection in prenatal care units in Abidjan, Côte d'Ivoire, and Bobo-Dioulasso, Burkina Faso, from November 1996 to April 1997 were eligible, with their informed consent. Women self administered daily a vaginal suppository of 1% BC (53) or matched placebo (54) from 36 weeks of pregnancy, plus a single dose during labour. The neonate was bathed with 1% BC solution or placebo within 30 minutes after birth. MTCT rate was assessed based on repeated polymerase chain reaction (PCR) and serology results. For the present analysis, children were followed up to 15 months.

Results: A total of 107 women were enrolled. Of 103 eligible liveborn children, 23 were HIV infected, 75 uninfected, and five of indeterminate status. MTCT transmission rate was 24.2% overall (95% confidence interval (CI): 14.3% to 30.4%). On an intent to treat basis, the transmission rate did not differ between the two groups (23.5%, CI 13.8 to 38.5, in the BC group and 24.8%, CI 15.0 to 39.6, in the placebo group at 15 months). Similarly, there was no difference in mortality at 15 months (22.9%, CI 13.7 to 36.9, in the BC group and 16.5%, CI 9.0 to 29.4, in the placebo group).

Conclusion: This analysis failed to suggest any benefit of BC disinfection on mother to child HIV transmission or perinatal and infant mortality.

Full Text

The Full Text of this article is available as a PDF (119.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. 15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group. Lancet. 1999 Dec 11;354(9195):2050–2051. [PubMed] [Google Scholar]
  2. Biggar R. J., Miotti P. G., Taha T. E., Mtimavalye L., Broadhead R., Justesen A., Yellin F., Liomba G., Miley W., Waters D. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet. 1996 Jun 15;347(9016):1647–1650. doi: 10.1016/s0140-6736(96)91486-5. [DOI] [PubMed] [Google Scholar]
  3. Burman L. G., Christensen P., Christensen K., Fryklund B., Helgesson A. M., Svenningsen N. W., Tullus K. Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. The Swedish Chlorhexidine Study Group. Lancet. 1992 Jul 11;340(8811):65–69. doi: 10.1016/0140-6736(92)90393-h. [DOI] [PubMed] [Google Scholar]
  4. Chuachoowong R., Shaffer N., Siriwasin W., Chaisilwattana P., Young N. L., Mock P. A., Chearskul S., Waranawat N., Chaowanachan T., Karon J. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis. 2000 Jan;181(1):99–106. doi: 10.1086/315179. [DOI] [PubMed] [Google Scholar]
  5. Dabis F., Elenga N., Meda N., Leroy V., Viho I., Manigart O., Dequae-Merchadou L., Msellati P., Sombie I., DITRAME Study Group 18-Month mortality and perinatal exposure to zidovudine in West Africa. AIDS. 2001 Apr 13;15(6):771–779. doi: 10.1097/00002030-200104130-00013. [DOI] [PubMed] [Google Scholar]
  6. Dabis F., Leroy V., Castetbon K., Spira R., Newell M. L., Salamon R. Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000. AIDS. 2000 May 26;14(8):1017–1026. doi: 10.1097/00002030-200005260-00014. [DOI] [PubMed] [Google Scholar]
  7. Dabis F., Msellati P., Dunn D., Lepage P., Newell M. L., Peckham C., Van de Perre P. Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. The Working Group on Mother-to-Child Transmission of HIV. AIDS. 1993 Aug;7(8):1139–1148. doi: 10.1097/00002030-199308000-00027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dabis F., Msellati P., Meda N., Welffens-Ekra C., You B., Manigart O., Leroy V., Simonon A., Cartoux M., Combe P. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant. Lancet. 1999 Mar 6;353(9155):786–792. doi: 10.1016/s0140-6736(98)11046-2. [DOI] [PubMed] [Google Scholar]
  9. Dabis F., Msellati P., Newell M. L., Halsey N., Van de Perre P., Peckham C., Lepage P. Methodology of intervention trials to reduce mother to child transmission of HIV with special reference to developing countries. International Working Group on Mother to Child Transmission of HIV. AIDS. 1995;9 (Suppl A):S67–S74. [PubMed] [Google Scholar]
  10. Duliège A. M., Amos C. I., Felton S., Biggar R. J., Goedert J. J. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. J Pediatr. 1995 Apr;126(4):625–632. doi: 10.1016/s0022-3476(95)70365-9. [DOI] [PubMed] [Google Scholar]
  11. Erny R., Siboni C. Les tampons au chlorure de benzalkonium. Tolérance locale et effets sur la glaire cervicale. J Gynecol Obstet Biol Reprod (Paris) 1983;12(7):767–774. [PubMed] [Google Scholar]
  12. Gaillard P., Mwanyumba F., Verhofstede C., Claeys P., Chohan V., Goetghebeur E., Mandaliya K., Ndinya-Achola J., Temmerman M. Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya. AIDS. 2001 Feb 16;15(3):389–396. doi: 10.1097/00002030-200102160-00012. [DOI] [PubMed] [Google Scholar]
  13. Gaillard P., Verhofstede C., Mwanyumba F., Claeys P., Chohan V., Mandaliya K., Bwayo J., Plum J., Temmerman M. Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS. 2000 Oct 20;14(15):2341–2348. doi: 10.1097/00002030-200010200-00015. [DOI] [PubMed] [Google Scholar]
  14. Graham W. J., Newell M. L. Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality. Lancet. 1999 Mar 6;353(9155):836–839. doi: 10.1016/S0140-6736(98)12374-7. [DOI] [PubMed] [Google Scholar]
  15. Mandelbrot L., Burgard M., Teglas J. P., Bénifla J. L., Khan C., Blot P., Vilmer E., Matheron S., Firtion G., Blanche S. Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS. 1999 Oct 22;13(15):2143–2149. doi: 10.1097/00002030-199910220-00018. [DOI] [PubMed] [Google Scholar]
  16. Mofenson L. M., McIntyre J. A. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet. 2000 Jun 24;355(9222):2237–2244. doi: 10.1016/S0140-6736(00)02415-6. [DOI] [PubMed] [Google Scholar]
  17. Msellati P., Meda N., Leroy V., Likikouët R., Van de Perre P., Cartoux M., Bonard D., Ouangre A., Combe P., Gautier-Charpentier L. Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV infected pregnant women in west Africa: ANRS 049b phase II randomized, double blinded placebo controlled trial. DITRAME Study Group. Sex Transm Infect. 1999 Dec;75(6):420–425. doi: 10.1136/sti.75.6.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nduati R., John G., Mbori-Ngacha D., Richardson B., Overbaugh J., Mwatha A., Ndinya-Achola J., Bwayo J., Onyango F. E., Hughes J. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000 Mar 1;283(9):1167–1174. doi: 10.1001/jama.283.9.1167. [DOI] [PubMed] [Google Scholar]
  19. Polednak A. P. Hospital volume and survival of breast cancer patients in Connecticut. Am J Public Health. 1999 Jun;89(6):946–947. doi: 10.2105/ajph.89.6.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sattar S. A., Springthorpe V. S. Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. Rev Infect Dis. 1991 May-Jun;13(3):430–447. doi: 10.1093/clinids/13.3.430. [DOI] [PubMed] [Google Scholar]
  21. Taha T. E., Biggar R. J., Broadhead R. L., Mtimavalye L. A., Justesen A. B., Liomba G. N., Chiphangwi J. D., Miotti P. G. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ. 1997 Jul 26;315(7102):216–220. doi: 10.1136/bmj.315.7102.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Van de Perre P., Meda N. Interventions to reduce mother to child transmission of HIV. AIDS. 1995;9 (Suppl A):S59–S66. [PubMed] [Google Scholar]
  23. Wainberg M. A., Spira B., Bleau G., Thomas R. Inactivation of human immunodeficiency virus type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride. J Clin Microbiol. 1990 Jan;28(1):156–158. doi: 10.1128/jcm.28.1.156-158.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES